CASI icon

CASI Pharmaceuticals

63 hedge funds and large institutions have $50.2M invested in CASI Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$887K
2 +$833K
3 +$807K
4
BlackRock
BlackRock
New York
+$674K
5
Ameriprise
Ameriprise
Minnesota
+$283K

Top Sellers

1 -$256K
2 -$253K
3 -$193K
4
TSS
Two Sigma Securities
New York
-$188K
5
MC
Moors & Cabot
Massachusetts
-$187K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$178K
27
$165K
28
$155K
29
$140K
30
$133K
31
$123K
32
$110K
33
$103K
34
$90K
35
$89K
36
$86.8K
37
$70K
38
$70K
39
$70K
40
$64K
41
$63K
42
$61K
43
$61K
44
$58K
45
$55K
46
$54K
47
$50K
48
$47K
49
$35K
50
$28K